Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats
阿托伐他汀与舒林酸或萘普生联合使用可通过抑制大鼠 p65/β-catenin/cyclin D1 信号通路显著抑制结肠腺癌
期刊:Cancer Prevention Research
影响因子:
doi:10.1158/1940-6207.CAPR-11-0222
Nanjoo Suh, Bandaru S Reddy, Andrew DeCastro, Shiby Paul, Hong Jin Lee, Amanda K Smolarek, Jae Young So, Barbara Simi, Chung Xiou Wang, Naveena B Janakiram, Vernon Steele, Chinthalapally V Rao
